Cargando…

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

INTRODUCTION: During HIV-1 infection the B-cell compartment undergoes profound changes towards terminal differentiation, which are only partially restored by antiretroviral therapy (cART). MATERIALS AND METHODS: To investigate the impact of infection as early as during primary HIV-1 infection (PHI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogliaghi, Manuela, Ripa, Marco, Pensieroso, Simone, Tolazzi, Monica, Chiappetta, Stefania, Nozza, Silvia, Lazzarin, Adriano, Tambussi, Giuseppe, Scarlatti, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608708/
https://www.ncbi.nlm.nih.gov/pubmed/26474181
http://dx.doi.org/10.1371/journal.pone.0140435
_version_ 1782395701523644416
author Pogliaghi, Manuela
Ripa, Marco
Pensieroso, Simone
Tolazzi, Monica
Chiappetta, Stefania
Nozza, Silvia
Lazzarin, Adriano
Tambussi, Giuseppe
Scarlatti, Gabriella
author_facet Pogliaghi, Manuela
Ripa, Marco
Pensieroso, Simone
Tolazzi, Monica
Chiappetta, Stefania
Nozza, Silvia
Lazzarin, Adriano
Tambussi, Giuseppe
Scarlatti, Gabriella
author_sort Pogliaghi, Manuela
collection PubMed
description INTRODUCTION: During HIV-1 infection the B-cell compartment undergoes profound changes towards terminal differentiation, which are only partially restored by antiretroviral therapy (cART). MATERIALS AND METHODS: To investigate the impact of infection as early as during primary HIV-1 infection (PHI) we assessed distribution of B-cell subsets in 19 PHI and 25 chronic HIV-1-infected (CHI) individuals before and during 48 weeks of cART as compared to healthy controls (n = 23). We also analysed Immunoglobulin-expression of memory B-cell subsets to identify alterations in Immunoglobulin-maturation. RESULTS: Determination of B-cell subsets at baseline showed that total and Naive B-cells were decreased whereas Activated Memory (AM), Tissue-like Memory (TLM) B-cells and Plasma cells were increased in both PHI and CHI patients. After 4 weeks of cART total B-cells increased, while AM, TLM B-cells and Plasma cells decreased, although without reaching normal levels in either group of individuals. This trend was maintained until week 48, though only total B-cells normalized in both PHI and CHI. Resting Memory (RM) B-cells were preserved since baseline. This subset remained stable in CHI, while was expanded by an early initiation of cART during PHI. Untreated CHI patients showed IgM-overexpression at the expenses of switched (IgM-IgD-) phenotypes of the memory subsets. Interestingly, in PHI patients a significant alteration of Immunoglobulin-expression was evident at BL in TLM cells, and after 4 weeks, despite treatment, in AM and RM subsets. After 48 weeks of therapy, Immunoglobulin-expression of AM and RM almost normalized, but remained perturbed in TLM cells in both groups. CONCLUSIONS: In conclusion, aberrant activated and exhausted B-cell phenotypes rose already during PHI, while most of the alterations in Ig-expression seen in CHI appeared later, despite 4 weeks of effective cART. After 48 weeks of cART B-cell subsets distribution improved although without full normalization, while Immunoglobulin-expression normalized among AM and RM, remaining perturbed in TLM B-cells of PHI and CHI.
format Online
Article
Text
id pubmed-4608708
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46087082015-10-29 Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets Pogliaghi, Manuela Ripa, Marco Pensieroso, Simone Tolazzi, Monica Chiappetta, Stefania Nozza, Silvia Lazzarin, Adriano Tambussi, Giuseppe Scarlatti, Gabriella PLoS One Research Article INTRODUCTION: During HIV-1 infection the B-cell compartment undergoes profound changes towards terminal differentiation, which are only partially restored by antiretroviral therapy (cART). MATERIALS AND METHODS: To investigate the impact of infection as early as during primary HIV-1 infection (PHI) we assessed distribution of B-cell subsets in 19 PHI and 25 chronic HIV-1-infected (CHI) individuals before and during 48 weeks of cART as compared to healthy controls (n = 23). We also analysed Immunoglobulin-expression of memory B-cell subsets to identify alterations in Immunoglobulin-maturation. RESULTS: Determination of B-cell subsets at baseline showed that total and Naive B-cells were decreased whereas Activated Memory (AM), Tissue-like Memory (TLM) B-cells and Plasma cells were increased in both PHI and CHI patients. After 4 weeks of cART total B-cells increased, while AM, TLM B-cells and Plasma cells decreased, although without reaching normal levels in either group of individuals. This trend was maintained until week 48, though only total B-cells normalized in both PHI and CHI. Resting Memory (RM) B-cells were preserved since baseline. This subset remained stable in CHI, while was expanded by an early initiation of cART during PHI. Untreated CHI patients showed IgM-overexpression at the expenses of switched (IgM-IgD-) phenotypes of the memory subsets. Interestingly, in PHI patients a significant alteration of Immunoglobulin-expression was evident at BL in TLM cells, and after 4 weeks, despite treatment, in AM and RM subsets. After 48 weeks of therapy, Immunoglobulin-expression of AM and RM almost normalized, but remained perturbed in TLM cells in both groups. CONCLUSIONS: In conclusion, aberrant activated and exhausted B-cell phenotypes rose already during PHI, while most of the alterations in Ig-expression seen in CHI appeared later, despite 4 weeks of effective cART. After 48 weeks of cART B-cell subsets distribution improved although without full normalization, while Immunoglobulin-expression normalized among AM and RM, remaining perturbed in TLM B-cells of PHI and CHI. Public Library of Science 2015-10-16 /pmc/articles/PMC4608708/ /pubmed/26474181 http://dx.doi.org/10.1371/journal.pone.0140435 Text en © 2015 Pogliaghi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pogliaghi, Manuela
Ripa, Marco
Pensieroso, Simone
Tolazzi, Monica
Chiappetta, Stefania
Nozza, Silvia
Lazzarin, Adriano
Tambussi, Giuseppe
Scarlatti, Gabriella
Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets
title Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets
title_full Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets
title_fullStr Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets
title_full_unstemmed Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets
title_short Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets
title_sort beneficial effects of cart initiated during primary and chronic hiv-1 infection on immunoglobulin-expression of memory b-cell subsets
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608708/
https://www.ncbi.nlm.nih.gov/pubmed/26474181
http://dx.doi.org/10.1371/journal.pone.0140435
work_keys_str_mv AT pogliaghimanuela beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT ripamarco beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT pensierososimone beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT tolazzimonica beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT chiappettastefania beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT nozzasilvia beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT lazzarinadriano beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT tambussigiuseppe beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets
AT scarlattigabriella beneficialeffectsofcartinitiatedduringprimaryandchronichiv1infectiononimmunoglobulinexpressionofmemorybcellsubsets